Screener
Ocular Therapeutix OCUL Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Net cash used in operating activities | (65,993) | (44,671) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (4,662) | (1,933) |
| Net cash used in investing activities | (4,662) | (1,933) |
| Cash flows from financing activities: | ||
| Proceeds from exercise of stock options | 294 | 4,183 |
| Net cash provided by financing activities | 294 | 4,183 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | (70,361) | (42,421) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's investing cash flow?
- Ocular Therapeutix (OCUL) reported investing cash flow of -$4.66M in Q1 2026.
- How has Ocular Therapeutix's investing cash flow changed year-over-year?
- Ocular Therapeutix's investing cash flow decreased by 141.2% year-over-year, from -$1.93M to -$4.66M.
- What is the long-term trend for Ocular Therapeutix's investing cash flow?
- Over 4 years (2021 to 2025), Ocular Therapeutix's investing cash flow has grown at a 77.6% compound annual growth rate (CAGR), from -$1.19M to -$11.88M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Ocular Therapeutix's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude